| Dr Adil Farooki, MD | |
|
680 Broadway, Paterson, NJ 07514-1524 | |
| (973) 754-0999 | |
| Not Available |
| Full Name | Dr Adil Farooki |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 680 Broadway, Paterson, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073718235 | NPI | - | NPPES |
| 0298476 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 256737 (New York) | Secondary |
| 207R00000X | Internal Medicine | 25MA08684400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Hackensack Meridian Health Pascack Valley Medical | Westwood, NJ | Hospital |
| Valley Hospital | Ridgewood, NJ | Hospital |
| Barnert Subacute Rehabilitation Center, Llc | Paterson, NJ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
| Mpv New Jersey Md Services Pc | 5991097669 | 120 |
News Archive
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
› Verified 2 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
› Verified 2 days ago
| Entity Name | Premier Medical Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093142895 PECOS PAC ID: 8123258118 Enrollment ID: O20140314000017 |
News Archive
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
› Verified 2 days ago
| Entity Name | Mpv New Jersey Md Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215391271 PECOS PAC ID: 5991097669 Enrollment ID: O20160718000760 |
News Archive
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adil Farooki, MD 35 Evergreen Pl, Demarest, NJ 07627-2441 Ph: (201) 467-5303 | Dr Adil Farooki, MD 680 Broadway, Paterson, NJ 07514-1524 Ph: (973) 754-0999 |
News Archive
Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
› Verified 2 days ago
David Paul Bleeker, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 21 Market St, Paterson, NJ 07501 Phone: 973-754-4200 Fax: 973-754-4201 | |
Walid Baddoura, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, St. Joseph's Regional Medical Center, Paterson, NJ 07503 Phone: 973-754-2270 | |
Dr. Dinesh H Shah, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 21st Ave, Paterson, NJ 07501 Phone: 973-345-1044 Fax: 973-345-3943 | |
Dr. Yana Cavanagh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, St. Joseph's Regional Medical Center, Internal Medicine, Paterson, NJ 07503 Phone: 973-754-2431 Fax: 973-754-3376 | |
Ruhin Yuridullah, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 802-318-7994 | |
Dr. Haris Kalatoudis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main Street, Medicine Department, Paterson, NJ 07503 Phone: 973-754-2000 |